Suraksha Diagnostic Ltd

Tue 18/08/2026,15:19:57 | NSE : SURAKSHA

₹317.158.70 (2.82%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 309.50

Previous Close

₹ 308.45

Volume

215788

Mkt Cap ( ₹ Cr)

₹ 1651.74

High

₹ 323.45

Low

₹ 309.50

52 Week High

₹ 333.00

52 Week Low

₹ 224.10

Book Value Per Share

₹ 47.01

Dividend Yield

0.00

Face Value

₹ 2.00

What's Your Call?

Collective community sentiment on Suraksha Diagnostic Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Suraksha Diagnostic Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Aug 2026, 4:59PM Suraksha Diagnostic Limited has informed the Exchange about Transcript
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Aug 2026, 4:35PM Suraksha Diagnostic Limited has informed the Exchange about Transcript
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    17 Aug 2026, 4:26PM The text Transcript of Earning call held on 13 August 2026 at 11:30 a.m. (IST)with respect to the unaudited (Standalone & Consolidated) Financial Resu
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Aug 2026, 4:05PM Suraksha Diagnostic Limited has informed the Exchange about Link of Recording
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Aug 2026, 3:23PM Suraksha Diagnostic Limited has informed the Exchange about Link of Recording
  • Suraksha Diagnostic - Copy of Newspaper Publication

    13 Aug 2026, 11:36AM Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    13 Aug 2026, 4:01PM Intimation of outcome of audio recording of analyst/Institutional Investor/Organizations meet-\Earning Call\ which was held today i.e. 13 August 2026
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    13 Aug 2026, 3:13PM Intimation of outcome of audio recording of Analyst/Institutional Investor/ Organizations meet-\Earning call\ held today i.e. 13 Auust 2026
  • Suraksha Diagnostic - Press Release

    12 Aug 2026, 7:21PM Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated August 12, 2026, titled "" Unaudited (standalone and consolidate
  • Suraksha Diagnostic - Investor Presentation

    12 Aug 2026, 7:14PM Suraksha Diagnostic Limited has informed the Exchange about Investor Presentation
  • Suraksha Diagnostic - Record Date

    12 Aug 2026, 7:10PM Suraksha Diagnostic Limited has informed the Exchange that Record date for the purpose of Dividend is 15-Sep-2026.
  • Suraksha Diagnostic - Appointment

    12 Aug 2026, 6:56PM Suraksha Diagnostic Limited has informed the Exchange regarding Appointment of Mr. Dinesh Gupta as Chief Financial Officer of the company w.e.f. Augus
  • Suraksha Diagnostic - Outcome of Board Meeting

    12 Aug 2026, 6:50PM Suraksha Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on August 12, 2026.
  • Suraksha Diagnostic - Outcome of Board Meeting

    12 Aug 2026, 6:47PM Suraksha Diagnostic Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Investor Presentation

    12 Aug 2026, 6:30PM Investor Presentation for quarter 1 ended 30 June 2026
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    12 Aug 2026, 6:23PM Press release in respect of unaudited ( Standalone and Consolidated) Financial Results for the quarter ended 30 June 2026
  • Suraksha Diagnostic - Corporate Action - Fixes Revised Record Date On 15 September 2026

    12 Aug 2026, 6:06PM Revised Record date if 15 September 2026 has been fixed
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Change in Management

    12 Aug 2026, 6:01PM Appointment of Chief Financial Officer of Mr. Dinesh Gupta
  • Suraksha Diagnostic - Results -Financial Results For Quarter Ended 30 June 2026

    12 Aug 2026, 5:54PM Approved unaudited financial results ( Standalone and Consolidated) of the company for quarter ended 30 June 2026
  • Suraksha Diagnostic - Board Meeting Outcome for Outcome Of Board Meeting Held Today, I.E 12 August 2026

    12 Aug 2026, 5:31PM Outcome of Board meeting held today, i.e 12 August 2026
  • Suraksha Diagnostic - General Updates

    10 Aug 2026, 1:01PM Suraksha Diagnostic Limited has informed the Exchange about General Updates
  • Suraksha Diagnostic - Intimation Of Postponement Of The 21St Annual General Meeting Of The Company

    10 Aug 2026, 12:25PM We wish to inform that the 21st Annual General Meeting of the Company which was scheduled to be held on Wednesday, 02 September 2026, stands postponed
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    7 Aug 2026, 5:26PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that there will be a Conf
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Aug 2026, 12:52PM Suraksha Diagnostic Limited has informed the Exchange about Schedule of meet
  • Suraksha Diagnostic - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Oblig

    4 Aug 2026, 5:15PM Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider
  • Suraksha Diagnostic has declared 25% Final dividend for the financial year March 2026

    25 Jul 2026, 7:00AM Suraksha Diagnostic Ltd. on Thursday, 21 May 2026, has announced Final dividend of 25 percent on Equity Share, to its shareholders holding shares on t
  • Suraksha Diagnostic has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    15 Jul 2026, 5:10PM As of June 2026, 49.10% is owned by Indian Promoters and 50.90% by Public. <p align=justify> Top five Promoters holding highest number of shares of Su
  • Suraksha Diagnostic - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Jul 2026, 5:49PM Suraksha Diagnostic Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Suraksha Diagnostic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jul 2026, 5:08PM Certificate under Regulation 74(5) of SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended 30 June, 2026.
  • Suraksha Diagnostic - Resignation of Director/KMP/SMP

    9 Jun 2026, 3:10PM Suraksha Diagnostic Limited has informed the Exchange about Resignation of Director/KMP/SMP
  • Suraksha Diagnostic - Cessation

    9 Jun 2026, 3:04PM Suraksha Diagnostic Limited has informed the Exchange regarding Cessation of Ms Mamta Jain as Company Secretary & Compliance Officer of the company w.
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    9 Jun 2026, 2:56PM Resignation of Ms. Mamta Jain, Company Secretary & Compliance Officer and Key Managerial Personnel (KMP) of the Company.
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    27 May 2026, 4:09PM Suraksha Diagnostic Limited has informed the Exchange about Transcript
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    27 May 2026, 4:23PM Transcript of the Earning Call held on Friday, 22 May 2026 with respect to the Audited (Standalone and Consolidated) Financial results of the Company
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    22 May 2026, 3:18PM Suraksha Diagnostic Limited has informed the Exchange about Link of audio recording of the Earnings Call in relation to the audited (standalone and co
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    22 May 2026, 2:37PM Intimation of audio recording of Analysts/Institutional Investors/Organisations meet-'Earnings Call'
  • Suraksha Diagnostic - Copy of Newspaper Publication

    22 May 2026, 11:48AM Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication
  • Suraksha Diagnostic - Press Release

    21 May 2026, 9:27PM Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated May 21, 2026, titled ""Audited (standalone and consolidated) fin
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    21 May 2026, 9:03PM Press release in respect of audited (standalone and consolidated) financial results for the quarter and financial year ended 31 March 2026
  • Suraksha Diagnostic - Investor Presentation

    21 May 2026, 7:42PM Suraksha Diagnostic Limited has informed the Exchange about Investor Presentation
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Investor Presentation

    21 May 2026, 7:37PM Investor Presentation for Q4 & FY 2025-26
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Change in Management

    21 May 2026, 7:24PM Re-appointment of M/s S Chhaparia & Associates as Cost Auditor for financial year ended 31 March 2026.
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Change in Management

    21 May 2026, 7:21PM Appointment of M/s Suresh Surana & Associates LLP as Internal Auditor of the Company for FY 2026-27.
  • Suraksha Diagnostic - Corporate Action-Board approves Dividend

    21 May 2026, 7:11PM Recommended dividend of ? 0.50 (Fifty Paise) per Equity Share of face value of ? 2/- each for FY 2025-26
  • Suraksha Diagnostic - Results -Financial Results For Quarter And Financial Year Ended 31 March 2026

    21 May 2026, 7:06PM Results-Financial results for quarter and financial year ended 31 March 2026
  • Suraksha Diagnostic Q4 net profit down 16.23% at Rs 6.71 cr

    21 May 2026, 7:00PM The company reported standalone net profit of Rs 6.71 crore for the quarter ended March 31, 2026 as compared to Rs 8.01 crore in the same period last
  • Suraksha Diagnostic - Outcome of Board Meeting

    21 May 2026, 6:56PM Suraksha Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on May 21, 2026.
  • Suraksha Diagnostic - Outcome of Board Meeting

    21 May 2026, 6:50PM Suraksha Diagnostic Limited has informed the Exchange regarding appointment/re-appointment of Internal Auditor and Cost Auditor for the financial year
  • Suraksha Diagnostic - Dividend

    21 May 2026, 6:45PM Suraksha Diagnostic Limited has informed the Exchange that Board of Directors at its meeting held on May 21, 2026, recommended Final Dividend of Rs. 0
  • Suraksha Diagnostic - Board Meeting Outcome for Meeting Held Today I.E 21 May 2026

    21 May 2026, 6:44PM Outcome of Board meeting held today, i.e 21 May 2026
  • Suraksha Diagnostic - Outcome of Board Meeting

    21 May 2026, 6:42PM Suraksha Diagnostic Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Key fundamentals

Evaluate the intrinsic value of Suraksha Diagnostic Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 251.4584 220.1374 189.5015 170.6301 169.0335
Liabilities 251.4584 220.1374 189.5015 170.6301 169.0335
Equity 10.4162 10.4162 6.9 6.9 6.9
Gross Profit 94.8042 82.5903 71.1917 44.9867 47.5072
Net Profit 34.0622 33.44 24.3839 7.189 23.751
Cash From Operating Activities 80.2293 62.798 61.23 44.9253 42.3306
NPM(%) 11.32 13.42 11.15 3.78 10.64
Revenue 300.6791 249.0954 218.5247 189.9854 223.1925
Expenses 205.8749 166.5051 147.333 144.9987 175.6853
ROE(%) 13.91 13.65 9.95 2.93 9.7

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
25 Aug 2026 0.5 25 0 320.1

Peers

Other companies within the same industry or sector that are comparable to Suraksha Diagnostic Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 831.05 3.10 21.02 176.24 -26.19 0.60
Lotus Eye Hospital and Institute Ltd 115.15 -0.59 1645.00 642.19 0.39 0.00
Vaishali Pharma Ltd 8.40 0.72 26.25 4028.67 15.42 0.00
Astec Lifesciences Ltd 586.50 0.98 0.00 688.07 -363.14 0.00

Company Info

The Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of Rs.300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of Rs.200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs.30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs.67 million.2023-Established our first 3T MRI and 128 CT at New Town

The Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of Rs.300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of Rs.200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs.30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs.67 million.2023-Established our first 3T MRI and 128 CT at New Town

Parent Organisation

Suraksha Diagnostic Ltd.

Founded

15/03/2005

Managing Director

Ms.Ritu Mittal

NSE Symbol

SURAKSHAEQ

FAQ